ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07809
-0,01%
Bitcoin
62.829,34
-0,35%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cidara Therapeutics Inc (CDTX)

  7. Cidara Therapeutics Inc (CDTX) News

CDTX

Cidara Therapeutics (CDTX)

Cidara Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CDTX
DatumZeitQuelleÜberschriftSymbolFirma
04/03/202422h22Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
23/02/202422h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CDTXCidara Therapeutics Inc
09/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
22/12/202313h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
17/11/202319h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
16/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
02/11/202321h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
02/11/202321h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTXCidara Therapeutics Inc
13/10/202316h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
21/09/202319h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
13/09/202322h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
13/09/202322h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
06/09/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
15/08/202301h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTXCidara Therapeutics Inc
03/08/202322h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTXCidara Therapeutics Inc
03/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTXCidara Therapeutics Inc
01/08/202316h30AllPennyStocks.comBiotech Rallies Right Before Opening BellNASDAQ:CDTXCidara Therapeutics Inc
23/06/202323h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
23/06/202323h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
23/06/202323h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
23/06/202323h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
23/06/202323h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
23/06/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDTXCidara Therapeutics Inc
11/05/202322h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDTXCidara Therapeutics Inc
11/05/202322h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDTXCidara Therapeutics Inc
27/04/202322h44Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDTXCidara Therapeutics Inc
27/04/202322h43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CDTXCidara Therapeutics Inc
29/03/202323h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
29/03/202323h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
28/03/202301h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDTXCidara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CDTX

Kürzlich von Ihnen besucht

FX
EURJPY
Euro vs Yen
TG
RHM
Rheinmetall
TG
DBK
Deutsche Bank
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
CCOM
US100
US Tech 100
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
TG
BAS
BASF
USOTC
ADDYY
Adidas (QX)
FX
EURUSD
Euro vs US Dollar
DBI
TDXP
Tec DAX
TG
LHA
Deutsche Lufthansa
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten